Albaracin, Kurt Jan S.
HRN: 10-06-38 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/26/2022
CEFUROXIME 1.5GM (VIAL)
07/26/2022
08/02/2022
IV
1.5g
Q8H
AP
Waiting Final Action
07/26/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/26/2022
08/02/2022
IV
500mg
Q8H
AP
Waiting Final Action